Capsule formulation of pirfenidone and pharmaceutically acceptable excipients

  • US 8,753,679 B2
  • Filed: 02/25/2013
  • Issued: 06/17/2014
  • Est. Priority Date: 09/22/2005
  • Status: Active Grant
First Claim
Patent Images

1. A capsule comprising a pharmaceutical formulation of 5-methyl-1-phenyl-2-(1H)-pyridone, wherein said pharmaceutical formulation comprises pharmaceutically acceptable excipients and 5-methyl-1-phenyl-2-(1H)-pyridone, and the formulation is stable for at least 9 months at 40°

  • C. at 75% relative humidity, as measured by a dissolution of at least 85% of the 5-methyl-1-phenyl-2-(1H)-pyridone after the at least 9 months.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×